Genetic Analysis of a Unique Human Immunodeficiency Virus Type 1 (HIV-1) with a Primer Binding Site Complementary to tRNA(Met) Supports a Role for U5-PBS Stem-Loop RNA Structures i...

di Kang, Sang-Moo, Morrow, Casey D.
Pubblicazione 1999

Enhancement of Mucosal Immunization with Virus-Like Particles of Simian Immunodeficiency Virus

di Kang, Sang-Moo, Compans, Richard W.
Pubblicazione 2003

Host responses from innate to adaptive immunity after vaccination: Molecular and cellular events

di Kang, Sang-Moo, Compans, Richard W.
Pubblicato in Mol Cells (2009)

Immunology and efficacy of MF59-adjuvanted vaccines

di Ko, Eun-Ju, Kang, Sang-Moo
Pubblicato in Hum Vaccin Immunother (2018)

Novel vaccines against influenza viruses

di Kang, Sang-Moo, Song, Jae-Min, Compans, Richard W.
Pubblicazione 2011

Virus-like particles as universal influenza vaccines

di Kang, Sang-Moo, Kim, Min-Chul, Compans, Richard W
Pubblicazione 2012

Protective CD8 T cell mediated immunity against influenza A virus infection following influenza virus-like particle vaccination

di Hemann, Emily A., Kang, Sang-Moo, Legge, Kevin L.
Pubblicazione 2013

Microneedle and mucosal delivery of influenza vaccines

di Kang, Sang-Moo, Song, Jae-Min, Kim, Yeu-Chun
Pubblicato in Expert Rev Vaccines (2012)

Oral vaccination with inactivated influenza vaccine induces cross-protective immunity

di Quan, Fu-Shi, Compans, Richard W., Kang, Sang-Moo
Pubblicato in Vaccine (2011)

Mucosal Immunization with Virus-Like Particles of Simian Immunodeficiency Virus Conjugated with Cholera Toxin Subunit B

di Kang, Sang-Moo, Yao, Qizhi, Guo, Lizheng, Compans, Richard W.
Pubblicazione 2003

Sequential immunizations with a panel of HIV-1 Env virus-like particles coach immune system to make broadly neutralizing antibodies

di Mohan, Teena, Berman, Zachary, Kang, Sang-Moo, Wang, Bao-Zhong
Pubblicato in Sci Rep (2018)

Universal influenza vaccines: From viruses to nanoparticles

di Wang, Ye, Deng, Lei, Kang, Sang-Moo, Wang, Bao-Zhong
Pubblicato in Expert Rev Vaccines (2018)

Virus-Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Influenza Virus

di Quan, Fu-Shi, Huang, Chunzi, Compans, Richard W., Kang, Sang-Moo
Pubblicazione 2007

Virus-Like Particle Vaccine Protects against 2009 H1N1 Pandemic Influenza Virus in Mice

di Quan, Fu-Shi, Vunnava, Aswani, Compans, Richard W., Kang, Sang-Moo
Pubblicazione 2010

Cutaneous immunization: an evolving paradigm in influenza vaccines

di Gill, Harvinder S, Kang, Sang-Moo, Quan, Fu-Shi, Compans, Richard W
Pubblicazione 2014

Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome

di Shin, Chong-Hyun, Kim, Ki-Hye, Jeeva, Subbiah, Kang, Sang-Moo
Pubblicato in Cells (2021)

Preferential Completion of Human Immunodeficiency Virus Type 1 Proviruses Initiated with tRNA(3)(Lys) rather than tRNA(1,2)(Lys)

di Zhang, Zhijun, Yu, Qin, Kang, Sang-Moo, Buescher, James, Morrow, Casey D.
Pubblicazione 1998

Intranasal Immunization with Inactivated Influenza Virus Enhances Immune Responses to Coadministered Simian-Human Immunodeficiency Virus-Like Particle Antigens

di Kang, Sang-Moo, Guo, Lizheng, Yao, Qizhi, Skountzou, Ioanna, Compans, Richard W.
Pubblicazione 2004

Induction of Heterosubtypic Immunity to Influenza Virus by Intranasal Immunization

di Quan, Fu-Shi, Compans, Richard W., Nguyen, Huan H., Kang, Sang-Moo
Pubblicazione 2008

Influenza vaccines based on virus-like particles

di Kang, Sang-Moo, Song, Jae-Min, Quan, Fu-Shi, Compans, Richard W.
Pubblicazione 2009